Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13484350 | 0.81 | ECE1 (0.39) | HSD17B10TDP1 | |
| SCHEMBL15868092 | 0.78 | ADRA1A (0.47) | — | |
| SCHEMBL23543321 | 0.77 | GAA (0.42) | TDP1 | |
| SCHEMBL6290055 | 0.76 | GAA (0.47) | TDP1 | |
| SCHEMBL22188002 | 0.75 | ACHE (0.46) | — | |
| SCHEMBL20048945 | 0.75 | MEN1 (0.47) | — | |
| SCHEMBL16140278 | 0.75 | GAA (0.43) | TDP1 | |
| SCHEMBL27455137 | 0.73 | ADRA1A (0.43) | — | |
| SCHEMBL12295177 | 0.73 | TDP1 (0.38) | HSD17B10TDP1 | |
| SCHEMBL13558758 | 0.71 | MEN1 (0.40) | HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100323949-A1 | ERYTHROPOIETIN MIMETIC PEPTIDE DERIVATIVE AND ITS PHARMACEUTICAL SALTS, THE PREPARATION AND USES THEREOF | JIANGSU HANSOH PHARMACEUTICAL CO., LTD. (CN) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100323949-A1 | ERYTHROPOIETIN MIMETIC PEPTIDE DERIVATIVE AND ITS PHARMACEUTICAL SALTS, THE PREPARATION AND USES THEREOF | EPOR, PROKR1, PROKR2 | HSD17B10 4225/4885TDP1 4718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.